University of Groningenfounded in 1614  -  top 100 university
Close
About us How to find us prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma
Telephone:
+31 50 361 5084 (secretary)
E-mail:
m.j.postma rug.nl

Research

Research units:

Advanced
Advanced

Reset

to
301 - 350 out of 731Page size: 50
  1. 2014
  2. Stevanovic, J., Pompen, M., Le, H. H., Rozenbaum, M. H., Tieleman, R. G., & Postma, M. J. (2014). Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands. PLoS ONE, 9(8), [e103974]. https://doi.org/10.1371/journal.pone.0103974
  3. van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., Postma, M. J., & Vegter, S. (2014). Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. Journal of Managed Care Pharmacy, 20(8), 786-792.
  4. Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P., Nord, E., Persson, U., ... Toumi, M. (2014). Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. Journal of Comparative Effectiveness Research, 3(4), 399-422. https://doi.org/10.2217/cer.14.34
  5. Vemer, P., & Postma, M. J. (2014). A few years later: Update of the cost-effectiveness of infant pneumococcal vaccination in Dutch children. Human vaccines & immunotherapeutics, 10(7), 1841-1849. https://doi.org/10.4161/hv.29008
  6. de Boer, P., Wilschut, J. C., & Postma, M. J. (2014). Cost-effectiveness of vaccination against herpes zoster. Human vaccines & immunotherapeutics, 10(7), 2048-2061. https://doi.org/10.4161/hv.28670
  7. Bergmeijer, T. O., Janssen, P. W. A., Schipper, J. C., Qaderdan, K., Ishak, M., Ruitenbeek, R. S., ... ten Berg, J. M. (2014). CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. American Heart Journal, 168(1), 16-22.e1. https://doi.org/10.1016/j.ahj.2014.03.006
  8. Le, H. H., Hodgkins, P., Postma, M. J., Kahle, J., Sikirica, V., Setyawan, J., ... Doshi, J. A. (2014). Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. European Child & Adolescent Psychiatry, 23(7), 587-598. https://doi.org/10.1007/s00787-013-0477-8
  9. Vegter, S., Oosterhof, P., van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E. G., & Postma, M. J. (2014). Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis. Journal of Managed Care Pharmacy, 20(7), 722-732. https://doi.org/10.18553/jmcp.2014.20.7.722
  10. Suwantika, A. A., Beutels, P., & Postma, M. J. (2014). Cost-effectiveness of hepatitis A vaccination in Indonesia. Human vaccines & immunotherapeutics, 10(8), 2342-2349. https://doi.org/10.4161/hv.29353
  11. van Boven, J. F. M., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G. O., ... Postma, M. J. (2014). Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: A cost-effectiveness analysis. Respiratory Research, 15(1), [66]. https://doi.org/10.1186/1465-9921-15-66
  12. Pitman, J. P., Wilkinson, R. L., Basavaraju, S. V., Von Finckenstein, B. G., Smit Sibinga, C. T. H., Marfin, A., ... Tobias, J. L. (2014). Investments in blood safety improve the availability of blood to underserved areas in a sub-saharan african country. Vox Sanguinis, 107(Supplement S1 (57-248)), 70-71. https://doi.org/10.1111/vox.12155
  13. Radke, P. W., Halvorsen, S., Jukema, J. W., Kolh, P., Annemans, L., Postma, M. J., ... Halcox, J. (2014). Networks for improving care in patients with acute coronary syndrome: A framework. Acute Cardiac Care, 16(2), 41-48. https://doi.org/10.3109/17482941.2014.881502
  14. Connolly, M. P., Kuyvenhoven, J. P., Postma, M. J., & Nielsen, S. K. (2014). Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2g mesalazine dosing. Journal of Crohn's and Colitis, 8(5), 357-362. https://doi.org/10.1016/j.crohns.2013.09.015
  15. Van Boven, J. F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G. G., ... Postma, M. J. (2014). Cost-effectiveness analysis of a pharmacist-led intervention on improving inhaler adherence in patients with chronic obstructive pulmonary disease. Value in Health, 17(3), A136. https://doi.org/10.1016/j.jval.2014.03.788
  16. Mihajlović, J., & Postma, M. J. (2014). Cost-effectiveness of targeted therapeutics in metastatic renal cell cancer seen from two different economic perspectives. Value in Health, 17(3), A90. https://doi.org/10.1016/j.jval.2014.03.525
  17. Nguyen, T. P. L., Schuiling-Veninga, N., Nguyen, T. B. Y., Hang, V. T. T., Wright, E. P., & Postma, M. J. (2014). Models to Predict the Burden of Cardiovascular Disease Risk in a Rural Mountainous Region of Vietnam. Value in Health Regional Issues, 3(1), 87-93. https://doi.org/10.1016/j.vhri.2014.03.003
  18. Stevanovic, J., Pehlivanoglou, P., & Postma, M. J. (2014). Meta-analysis of preference-based quality of life values in heart failure. Value in Health, 17(3), A197-A197. https://doi.org/10.1016/j.jval.2014.03.1152
  19. De Cao, E., Melegaro, A., Klok, R., & Postma, M. (2014). Optimising assessments of the epidemiological impact in the Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. PLoS ONE, 9(4), [e89415]. https://doi.org/10.1371/journal.pone.0089415
  20. Van Hasselt, F. M., Oud, M. J. T., Krabbe, P. F. M., Postma, M. J., & Loonen, A. J. M. (2014). Improving somatic health of outpatients with severe mental illness. Schizophrenia Research, 153(Supplement 1), S186-S187.
  21. Suwantika, A. A., Zakiyah, N., Lestari, K., & Postma, M. J. (2014). Accelerating the introduction of rotavirus immunization in Indonesia. Expert review of vaccines, 13(4), 463-472. https://doi.org/10.1586/14760584.2014.891940
  22. Parouty, M. B. Y., Le, H., Krooshof, D., & Postma, M. J. (2014). Differential time preferences for money and quality of life. Pharmacoeconomics, 32(4), 411-419. https://doi.org/10.1007/s40273-013-0124-8
  23. Stevanovic, J., O'Prinsen, A. C., Verheggen, B. G., Schuiling-Veninga, N., Postma, M. J., & Pechlivanoglou, P. (2014). Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension: A Scenario Analysis for the Netherlands. Clinical Therapeutics, 36(3), 368-384. https://doi.org/10.1016/j.clinthera.2014.01.008
  24. de Vries, F. M., Denig, P., Visser, S. T., Hak, E., & Postma, M. J. (2014). Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands. Value in Health, 17(2), 223-230. https://doi.org/10.1016/j.jval.2013.12.010
  25. van Boven, J. F. M., Novak, A., Driessen, M. T., Boersma, C., Boomsma, M. M., & Postma, M. J. (2014). Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands. Drugs & Aging, 31(3), 193-201. https://doi.org/10.1007/s40266-013-0150-4
  26. Moolenaar, L. M., Connolly, M., Huisman, B., Postma, M. J., Hompes, P. G. A., van der Veen, F., & Mol, B. W. J. (2014). Costs and benefits of individuals conceived after IVF: a net tax evaluation in The Netherlands. Reproductive Biomedicine Online, 28(2), 239-245. https://doi.org/10.1016/j.rbmo.2013.10.002
  27. Standaert, B. A., Curran, D., & Postma, M. J. (2014). Budget constraint and vaccine dosing: A mathematical modelling exercise. Cost Effectiveness and Resource Allocation, 12(3), [3]. https://doi.org/10.1186/1478-7547-12-3
  28. Huang, Y., Zhou, Q., Haaijer-Ruskamp, F. M., & Postma, M. J. (2014). Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review. Bmc nephrology, 15(1), [15]. https://doi.org/10.1186/1471-2369-15-15
  29. Mafirakureva, N., Khoza, S., Mvere, D. A., Chitiyo, M. E., Postma, M. J., & Van Hulst, M. (2014). Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: A retrospective analysis. Blood transfusion, 12(3), 362-367. https://doi.org/10.2450/2014.0156-13
  30. van Boven, J. F. M., Chavannes, N. H., van der Molen, T., Rutten-van Molken, M. P. M. H., Postma, M. J., & Vegter, S. (2014). Clinical and economic impact of non-adherence in COPD: A systematic review. Respiratory Medicine, 108(1), 103-113. https://doi.org/10.1016/j.rmed.2013.08.044
  31. Parouty, M. B. Y., & Postma, M. J. (2014). A probabilistic theory for intertemporal indifference. Theoretical Economics Letters, 4(6), 415-424. [46834]. https://doi.org/10.4236/tel.2014.46053
  32. Wouters, H., Quik, E. H., Boersma, F., Nygard, P., Bosman, J., Bottger, W. M., ... Taxis, K. (2014). Discontinuing Inappropriate Medication in Nursing Home Residents (DIM-NHR Study): Protocol of a cluster randomised controlled trial. BMJ Open, 4(10), [e006082]. https://doi.org/10.1136/bmjopen-2014-006082
  33. Postma, M., & Boersma, C. (2014). Farmaco-economie. In HJ. Out, P. van Meurs, & R. van Olden (Eds.), Handboek farmaceutische geneeskunde (Vol. Hoofdstuk 7, pp. 99-118). Houten: Bohn, Stafleu, Van Loghum.
  34. van Boven, J. FM., Stuurman-Bieze, A. GG., Hiddink, E. G., Postma, M. J., & Vegter, S. (2014). Gerichte farmaceutische zorg voor patiënten met astma en COPD: een oriënterende studie. Pharmaceutisch Weekblad Wetenschappelijk Platform, 149(12), 49-53. [8:A1413].
  35. van Boven, J., Tommelein, E., Mehuys, E., Vegter, S., Brusselle, G. GO., Rutten-van Molken, M. P. M. H., & Postma, M. (2014). Het optimaliseren van de farmacotherapie bij patiënten met Chronisch Obstructief Longlijden (COPD) in de officina-apotheek: een kosten-effectiviteitsanalyse[1]. Farmaceutisch Tijdschrift voor België, 94(3), 15-16.
  36. Postma, M. (2014). Kosten van de zorg wegen we af tegen langer en/of aangenamer leven. In V. M. (Ed.), Gezonder ouder worden in Nederland (pp. 31-33). [Hoofdstuk 10] Breda: NPN Drukkers.
  37. Pechlivanoglou, P., Le, H. H., Daenen, S., Snowden, J. A., & Postma, M. J. (2014). Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: A systematic review. Journal of Antimicrobial Chemotherapy, 69(1), 1-11. https://doi.org/10.1093/jac/dkt329
  38. 2013
  39. Meijboom, M. J., Pouwels, K. B., Luytjes, W., Postma, M., & Hak, E. (2013). RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population. Vaccine, 31(52), 6254-6260. https://doi.org/10.1016/j.vaccine.2013.10.023
  40. Van Boven, J. F. M., Vegter, S., Van Der Molen, T., & Postma, M. J. (2013). COPD in the working age population: The economic impact on both patients and government. COPD: Journal of Chronic Obstructive Pulmonary Disease, 10(6), 629-639. https://doi.org/10.3109/15412555.2013.813446
  41. Suwantika, A. A., & Postma, M. J. (2013). Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia. BMC Public Health, 13, [1106]. https://doi.org/10.1186/1471-2458-13-1106
  42. Mihajlovic, J., Pechlivanoglou, P., Sabo, A., Tomic, Z., & Postma, M. J. (2013). Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia. Clinical Therapeutics, 35(12), 1909-1922. https://doi.org/10.1016/j.clinthera.2013.10.004
  43. Suwantika, A. A., Yegenoglu, S., Riewpaiboon, A., Tu, H-A. T., & Postma, M. J. (2013). Economic evaluations of hepatitis A vaccination in middle-income countries. Expert review of vaccines, 12(12), 1479-1494. https://doi.org/10.1586/14760584.2013.851008
  44. van Boven, J. F. M., Hiddink, E. G., Stuurman-Bieze, A. G. G., Schuiling-Veninga, N., Postma, M., & Vegter, S. (2013). The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. International Journal of Clinical Pharmacy, 35(6), 1075-1082. https://doi.org/10.1007/s11096-013-9829-1
  45. Kotsopoulos, N., Connolly, M. P., Postma, M. J., & Hutubessy, R. C. W. (2013). Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation. Vaccine, 31(46), 5430-5434. https://doi.org/10.1016/j.vaccine.2013.09.002
  46. Mihajlović, J., Minović, I., Bruinsma, A., & Postma, M. J. (2013). Cost utility analysis of everolimus in the treatment of metastatic renal cell cancer in the Netherlands. Value in Health, 16(7), 416. https://doi.org/10.1016/j.jval.2013.08.534
  47. Vegter, S., Oosterhof, P., Van Boven, J. F., Stuurman-Bieze, A. G. G., Hiddink, E. G., & Postma, M. J. (2013). Cost-effectiveness of increasing statin adherence for primary and secondary prevention in community pharmacies. Value in Health, 16(7), 528. https://doi.org/10.1016/j.jval.2013.08.1295
  48. Vemer, P., & Postma, M. J. (2013). Cost-effectiveness of infant pneumococcal vaccination in the Netherlands. Value in Health, 16(7), 334. https://doi.org/10.1016/j.jval.2013.08.073
  49. De Boer, P. T., & Postma, M. J. (2013). Cost-effectiveness of universal vaccination ag ainst varicella in the Netherlands. Value in Health, 16(7), A357. https://doi.org/10.1016/j.jval.2013.08.203
  50. Stevanovic, J., Pompen, M., Le, H. H., Rozenbaum, M. H., & Postma, M. J. (2013). Economic evaluation of apixaban for the prevention of stroke in atrial fibrillation in the Netherlands. Value in Health, 16(7), A529-530. https://doi.org/10.1016/j.jval.2013.08.1303
  51. De Vries, F. M., Denig, P., Vegter, S., Bos, H. J., Postma, M. J., & Hak, E. (2013). Effects of the occurrence of a first cardiovascular event on statin adherence in type 2 diabetes: A matched cohort design. Value in Health, 16(7), 532-533. https://doi.org/10.1016/j.jval.2013.08.1320
  52. Le, H. H., Pechlivanoglou, P., & Postma, M. J. (2013). Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands. Value in Health, 16(7), A514. https://doi.org/10.1016/j.jval.2013.08.1213
Previous 1...3 4 5 6 7 8 9 10 ...15 Next

ID: 193217

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube